These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7013767)

  • 1. Cytochrome P-450: a pharmacological necessity or a biochemical curiosity?
    Burke MD
    Biochem Pharmacol; 1981 Feb; 30(3):181-7. PubMed ID: 7013767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 3. The 1980 Bernard B. Brodie award lecture. Drug metabolism by cytochrome P-450: progress and perspectives.
    Coon MJ
    Drug Metab Dispos; 1981; 9(1):1-4. PubMed ID: 6111423
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: clinically significant cytochrome P-450 drug interactions.
    Michalets EL
    Pharmacotherapy; 1998; 18(1):84-112. PubMed ID: 9469685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of metabolic drug-drug interactions: a descriptive and critical commentary.
    Li AP
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.25. PubMed ID: 23045147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of drug interactions: putative time courses after mechanism-based inhibition or induction of CYPs.
    Imai H; Kotegawa T; Ohashi K
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):409-11. PubMed ID: 22114850
    [No Abstract]   [Full Text] [Related]  

  • 8. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes.
    Dmitriev AV; Lagunin AA; Karasev DА; Rudik AV; Pogodin PV; Filimonov DA; Poroikov VV
    Curr Top Med Chem; 2019; 19(5):319-336. PubMed ID: 30674264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions: Part I.
    Gibaldi M
    Ann Pharmacother; 1992 May; 26(5):709-13. PubMed ID: 1591436
    [No Abstract]   [Full Text] [Related]  

  • 11. Understanding cooperativity in human p450 mediated drug-drug interactions.
    Sligar SG; Denisov IG
    Drug Metab Rev; 2007; 39(2-3):567-79. PubMed ID: 17786639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ; Lake BG
    Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
    Dansette PM; Delaforge M; Sartori E; Beaune P; Jaouen M; Mansuy D
    Adv Exp Med Biol; 1986; 197():155-62. PubMed ID: 3490132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CYPs: in vivo and clinical aspects.
    Pelkonen O
    Drug Metab Rev; 2002; 34(1-2):37-46. PubMed ID: 11996010
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiplicity of liver drug metabolizing enzymes.
    Lu AY
    Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of in vitro human metabolism studies in drug development. An industrial perspective.
    Rodrigues AD
    Biochem Pharmacol; 1994 Dec; 48(12):2147-56. PubMed ID: 7811296
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of age and of the inducer phenobarbital on the cytochrome P-450 dependent monooxygenation of drugs in rat liver.
    Müller D; Klinger W
    Pharmazie; 1978 Jul; 33(7):397-400. PubMed ID: 103104
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-pharmacological aspects of enzyme induction].
    Bartłomowicz B
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.